Innocan, Pharma

Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Innocan Pharma Corporation Canada Ontario Israel

en | boerse | 67982886 |